WILLIAM M OUTLAW

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology GREENSBORO, NC NPI 1346353315

General Payments — all program years on this page

$3,119.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 209
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $367.19 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $367.1920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $643.3640
2019 $833.2663
2020 $290.1417
2021 $187.6713
2022 $396.4625
2023 $401.0031
2024 $367.1920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078830706 Janssen Biotech, Inc. $16.15 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078830779 Janssen Biotech, Inc. $17.80 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096851838 Novo Nordisk Inc $16.65 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163227 ABBVIE INC. $13.50 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163229 ABBVIE INC. $16.43 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163231 ABBVIE INC. $21.46 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163233 ABBVIE INC. $16.73 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163235 ABBVIE INC. $27.08 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105163237 ABBVIE INC. $24.58 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117646951 Amgen Inc. $25.48 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139913789 GENZYME CORPORATION $22.78 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141714724 Merck Sharp & Dohme LLC $14.56 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141714726 Merck Sharp & Dohme LLC $14.29 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141714728 Merck Sharp & Dohme LLC $15.60 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141873841 Merck Sharp & Dohme LLC $16.46 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146953608 Fresenius Kabi USA, LLC $14.82 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153594303 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.52 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153600303 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.88 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153617363 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.77 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153771834 IRONWOOD PHARMACEUTICALS, INC $15.65 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.